Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LX4211 DDI with Digoxin in Healthy Subjects
NCT02300350Phase 1Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Oct 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sotagliflozin in type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2DM), sponsored by Lexicon Pharmaceuticals, Inc. Primary endpoint: Area Under the Curve. Started Oct 2014; status: completed.
02
Drugs
sotagliflozin
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02300350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02300350.